Making sense of the ZB acquisition of P28

By

This one was hard to gather my thoughts on. It's kinda boring when a public company buys another public company to bolster their lack of R&D production, extend their product portfolio and upgrade their sales distribution. Let me try.
Zimmer Biomet (ZB) is acquiring Paragon 28 for $1.1 billion in equity, with a potential additional $1 per share if revenue targets are met in 2026, bringing the total enterprise value to $1.2 billion.
First read the ZB point of view - an internal Powerpoint to employees that has leaked -" ZB Acquisition of Paragon 28" (8 slides).
investor-deck-zbh-definitive...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.